NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ONI

ONI

Private
OxfordHealthcare & Life Scienceshttps://oni.bio/

Last Round

Series B

Jan 20, 2022

Est. Valuation

$100M

Total Funding Raised

$105.7M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

ONI is a biotechnology company that develops single-molecule super-resolution microscopes to enhance biological research by allowing researchers to visualize and analyze molecules and structures within living cells.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Imaging, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Data as a Service, Subscription SaaS

AI Layer

Application

Keywords

super-resolution microscopysingle-molecule imaginglipid nanoparticle characterizationLNP characterizationdrug target validationbenchtop microscopeextracellular vesicle researchEV researchautomated sample preparationscientific instrumentationlab automationbiotech hardwareimage analysis softwarebio-imagingsample-to-answer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ONI Comparables

Compare ONI with similar companies based on industry and business-model similarity.

ONI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Abberior Instruments
82%
Abbelight
80%
Bruker
74%

ONI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJan 20, 2022
GrantJan 1, 2021
Series AJul 1, 2018
SeedApr 1, 2017
SeedMay 10, 2016

Key People

Founding team and executive leadership

Alex Aravanis

Chief Executive Officer And Co-Founder

Founding Team

Paul Scagnetti

Chief Executive Officer

Executive Team

Tyler Ralston

Chief Technology Officer

Executive Team

Brenton Keath

Chief Financial Officer

Executive Team

ONI Investors

Notable investors and investment history

ONI investors
InvestorRounds
S32Series B
IP GroupSeries A
Oxford Science EnterprisesSeries B, Seed
ARCH Venture PartnersSeries B
ARTIS VenturesSeries B
Axon VenturesSeries B
ARCH Venture PartnersSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 24, 2026

    Launched LNP PREP for sample-to-answer automation.

  • Jan 15, 2026

    Added azimp-micro, an electronics distributor, as a customer.

ONI Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ONI Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ONI's valuation, stock price, and market status.

Firmographic Details

HeadquartersOxford
Employee Range201
Year Founded2016
Last FundingJan 20, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.